Cargando…
Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years
BACKGROUND: A decrease in breast density due to tamoxifen preventive therapy might indicate greater benefit from the drug. It is not known whether mammographic density continues to decline after 1 year of therapy, or whether measures of breast density change are sufficiently stable for personalised...
Autores principales: | Brentnall, Adam R., Warren, Ruth, Harkness, Elaine F., Astley, Susan M., Wiseman, Julia, Fox, Jill, Fox, Lynne, Eriksson, Mikael, Hall, Per, Cuzick, Jack, Evans, D. Gareth, Howell, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523310/ https://www.ncbi.nlm.nih.gov/pubmed/32993747 http://dx.doi.org/10.1186/s13058-020-01340-4 |
Ejemplares similares
-
The Relationship between Body Mass Index and Mammographic Density during a Premenopausal Weight Loss Intervention Study
por: Atakpa, Emma C., et al.
Publicado: (2021) -
Use of Low-Dose Tamoxifen to Increase Mammographic Screening Sensitivity in Premenopausal Women
por: Eriksson, Mikael, et al.
Publicado: (2021) -
Exploring the prediction performance for breast cancer risk based on volumetric mammographic density at different thresholds
por: Wang, Chao, et al.
Publicado: (2018) -
A novel and fully automated mammographic texture analysis for risk prediction: results from two case-control studies
por: Wang, Chao, et al.
Publicado: (2017) -
A case–control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density
por: Brentnall, Adam R., et al.
Publicado: (2019)